Transcribed Image Text from this Question
B B B B $ IX 0 HO G New + # D el REDCCB B ass.waldenu edu/webapps/blackboard/execute/announcement?method=search&context=mybb&course_id=16812611_1&viewChoice2 Here is what you would do to learn & teach as well as score well on Week 5 diabetes discussion: Post a brief explanation of the differences between the types of diabetes, mainly type 1, type 2. Describe the differences in the pharmacological management of type I and Type Il diabetes, as a short paragraph. Mention the classes of drugs used in type Il diabetes management as a short paragraph. Describe one type of drug used (that are presently well used) to treat the type of diabetes you selected (either from type I and type II), including proper preparation and administration of this drug. Discussion should include advanced pharmacokinetics & pharmacodynamics of the agent you have selected. Peer discussions also should include scholarly references. No patient based, trivial or old references. Peer discussions should have focus on pharmacological details of drugs of relevance. Be sure to include dietary considerations related to treatment. Then, explain the short-term and long- term impact of this type of diabetes on patients, including effects of drug treatments. Be specific and provide examples Peer replies should be in-depth discussion, in focus, at advanced pharmacology of diabetes. I need to see the discussions done well at the highest prescription clinician levels addressing kinetics & dynamics of drugs of relevance. Newer Diabetes agents: JFYI (try to include them in your discussion, you could score bonus points!) Dipeptidyl peptidase 4 inhibitors (DPP-IV inhibitors): They are called gliptins, MOA: Gliptins stops DPP-4 INTL
(Visited 1 times, 1 visits today)
